Scorpion Therapeutics is a biotechnology company focused on advancing precision oncology by developing next-generation cancer treatments. Their innovative approach targets the molecular drivers of cancer, aiming to expand the reach and effectiveness of precision medicine. With a strong foundation in cancer biology, medicinal chemistry, and computational technologies, Scorpion Therapeutics strives to deliver therapies that improve patient outcomes by precisely targeting cancer's unique mechanisms.
Founded: 2020
Adam Friedman, MD, Ph.D. CEO |
Mark Chao, MD, Ph.D. Chief Medical Officer |
Erica L. Jackson, Ph.D. Chief Discovery Officer |
Brian Piper CFO |
Kristin Schuhwerk COO |
Darrin Stuart, Ph.D. Chief Scientific Officer |
Amanda Valentino Chief People Officer |